scPharmaceuticals Inc. (SCPH) News
Filter SCPH News Items
SCPH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
SCPH News Highlights
- For SCPH, its 30 day story count is now at 4.
- Over the past 27 days, the trend for SCPH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest SCPH News From Around the Web
Below are the latest news stories about SCPHARMACEUTICALS INC that investors may wish to consider to help them evaluate SCPH as an investment opportunity.
scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BURLINGTON, Mass., Feb. 06, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (“scPharmaceuticals” or the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that on February 1, 2023, the Compensation Committee of scPharmaceuticals’ board of directors granted inducement equity grants consisting of stock options to purchase an aggregate |
scPharmaceuticals to Participate in the SVB Securities Global Biopharma ConferenceBURLINGTON, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to present virtually at the SVB Securities Global Biopharma Conference, on Thursday, February 16 at 11:20 am ET. Mr. Tucker wi |
scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial UpdateCommercial launch planned for February 20, 2023BURLINGTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that the company is targeting February 20, 2023 as the date for commercial availability of FUROSCIX® (furosemide injection), a proprietary formulation of furosemide delive |
scPharmaceuticals Inc. (NASDAQ:SCPH) stock most popular amongst private equity firms who own 41%, while individual investors hold 36%If you want to know who really controls scPharmaceuticals Inc. ( NASDAQ:SCPH ), then you'll have to look at the makeup... |
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call TranscriptscPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript November 12, 2022 Operator: Greetings, and welcome to the scPharmaceuticals Third Quarter 2022 Earnings Call. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Hans Vitzthum. Thank you, Mr. Vitzthum. You may begin. Hans Vitzthum: Thank you, operator. Before […] |
What Makes scPharmaceuticals, Inc. (SCPH) a New Buy StockscPharmaceuticals, Inc. (SCPH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
Has scPharmaceuticals (SCPH) Outpaced Other Medical Stocks This Year?Here is how scPharmaceuticals, Inc. (SCPH) and Syndax Pharmaceuticals (SNDX) have performed compared to their sector so far this year. |
scPharmaceuticals names Rachael Nokes as CFOscPharmaceuticals (SCPH) said Monday it appointed Rachael Nokes, SVP of finance, as CFO.Nokes joined the company in 2014 from BG Medicine, a publicly traded medical device company,… |
scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial OfficerAppointment brings more than 20 years of life sciences finance leadership experience to the CFO roleBURLINGTON, Mass., Dec. 19, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced the appointment of Rachael Nokes as Chief Financial Officer. Ms. Nokes previously served as scPharmaceuticals’ Senior |
scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access EventBURLINGTON, Mass., Dec. 14, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to participate in the 12th Annual LifeSci Partners Corporate Access Event, on Monday, January 9 and Tuesday, January 10, 2023, |